KR950011103B1 - Preparation of 6,10,14,18-tetrasmethyl-5,9,13,17-nonadecatetraene-2-one - Google Patents

Preparation of 6,10,14,18-tetrasmethyl-5,9,13,17-nonadecatetraene-2-one Download PDF

Info

Publication number
KR950011103B1
KR950011103B1 KR1019920008284A KR920008284A KR950011103B1 KR 950011103 B1 KR950011103 B1 KR 950011103B1 KR 1019920008284 A KR1019920008284 A KR 1019920008284A KR 920008284 A KR920008284 A KR 920008284A KR 950011103 B1 KR950011103 B1 KR 950011103B1
Authority
KR
South Korea
Prior art keywords
compound
formula
mmol
added
crude product
Prior art date
Application number
KR1019920008284A
Other languages
Korean (ko)
Other versions
KR930023321A (en
Inventor
박외숙
안수경
Original Assignee
대광제약주식회사
김병주
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 대광제약주식회사, 김병주 filed Critical 대광제약주식회사
Priority to KR1019920008284A priority Critical patent/KR950011103B1/en
Publication of KR930023321A publication Critical patent/KR930023321A/en
Application granted granted Critical
Publication of KR950011103B1 publication Critical patent/KR950011103B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

6,10,14,18-Tetramethyl-5,9,13,17-nonadekatetraen-2-on of formula (I) is prepared by : reacting the cpd. of formula (4) with the cpd. of formula (7) to obtain the cpd. of formula (8); treating the cpd. (8) to obtain the cpd. of formula (9); and removing the protecting gp. from the cpd. (9). In the formulas, R is lower alkyl, bezene or toluene; m is 0 or 1; n is 1 or 2 (if m=0 then n=2, if m=1 then n=1); X is halogen. The obtd. cpd. (I) is useful for treatment of ulcer.

Description

6,10,14,18-테트라메틸-5,9,13,17-노나데카테트라엔-2-온의 제조방법Method for preparing 6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraen-2-one

본 발명은 다음 구조식(I)의 6,10,14,18-테트라메틸-5,9,13,17-노나데카테트라엔-2-온의 제조방법에 관한 것이다.The present invention relates to a method for preparing 6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraen-2-one of formula (I).

상기 구조식 (I)의 화합물은 공지화합물로 항궤양효과를 가진 화합물로 알려져 있다. 상기 구조식 (I)의 화합물은 유럽특허 제207 505호에 그 제조 방법이 제시되어 있다.The compound of formula (I) is a known compound and is known as a compound having an antiulcer effect. The compound of formula (I) is described in EP 207 505.

상기 구조식 (I)의 화합물은 다음 구조식 (III)의 화합물을 다음 구조식(IV)의 화합물과 축합반응시킨후 탈카르복실화시켜서 제조하거나,The compound of formula (I) is prepared by condensation reaction of a compound of formula (III) with a compound of formula (IV), followed by decarboxylation,

또는, 다음 구조식 (V)의 화합물을 다음 구조식 (IV)의 화합물과 반응시켜서 제조하였다.Alternatively, the compound of formula (V) is prepared by reacting with the compound of formula (IV).

그러나, 상기의 제조방법은 그 출발물질의 제조방법이 복잡하고 수율도 낮은 문제점이 있었다.However, the above production method has a problem in that the production method of the starting material is complicated and the yield is also low.

본 발명자들은 상기 구조식(I)의 화합물의 제조방법에 관하여 오랜 연구를 행한 결과, 간단한 방법으로 높은 수율과 순도로 목접화합물인 구조식(I)의 화합물을 제조할 수 있는 방법을 개발하여 본 발명을 완성하였다.The present inventors have conducted a long study on the preparation method of the compound of the formula (I), and as a result, by developing a method for producing a compound of the formula (I) which is an oral compound with a high yield and purity by a simple method Completed.

따라서 본 발명의 목적은 개량된 구조식(I)의 화합물의 제조방법을 제공하는 것이다.It is therefore an object of the present invention to provide an improved process for the preparation of compounds of formula (I).

본 발명은 다음에서 상세히 설명한다.The invention is explained in detail in the following.

본 발명은 다음 일반구조식 (4)의 화합물을 다음 일반구조식 (7)의 화합물과 반응시켜서 얻어진 다음 일반구조식(8)의 화합물을 처리하여 얻어진 다음 일반구조식(9)의 화합물로부터 보호기를 제거하여 일반구조식 (I)의 화합물을 제조한다.The present invention is obtained by reacting a compound of the general formula (4) with a compound of the following general formula (7) and then removing a protecting group from the compound of the following general formula (9) To prepare a compound of formula (I).

식중 R은 저급알킬, 벤젠, 톨로엔이며, m은 0 또는 1이고 n은 1 또는 2이며(단 m이 0이면 n은 2이며, m이 1이면 n도 동시에 1이다.), X는 할로겐원자이다.Wherein R is lower alkyl, benzene, toloene, m is 0 or 1, n is 1 or 2 (where n is 2 if m is 0 and n is 1 at the same time) It is an atom.

구조식(4)의 화합물은 다음 일반구조식 (1)의 화합물을 에틸렌글리콜과 반응시켜서 카르보닐기를 보호하여 다음 일반구조식 (2)의 화합물을 제조한 후, 여기에 하이드록실기를 도입하여 일반구조식 (3)의 화합물을 제조하고 이 하이드록실기를 할로겐기로 전환시켜서 제조하며, 반응식으로 나타내면 다음과 같다.The compound of formula (4) is prepared by reacting a compound of formula (1) with ethylene glycol to protect a carbonyl group to prepare a compound of formula (2), and then introducing a hydroxyl group to the formula (3). ) Is prepared by converting the hydroxyl group to a halogen group, represented by the reaction scheme.

식중 m 및 x는 전술한 바와 같다.Wherein m and x are as described above.

일반구조식 (7)의 화합물은 일반구조식 (5)의 화합물의 하이드록실기를 할로겐능로 전환시킨 후 알킬 또는 아릴설포닐기로 치환시켜서 제조하며, 반응식으로 나타내면 다음과 같다.The compound of the general formula (7) is prepared by converting the hydroxyl group of the compound of the general formula (5) to a halogen function and then replacing with an alkyl or arylsulfonyl group.

식중, R, n 및 X는 전술한 바와 같다.Wherein R, n and X are as described above.

일반구조식 (1)의 화합물 및 일반구조식 (5)의 화합물은 공지의 화합물이다.The compound of the general formula (1) and the compound of the general formula (5) are known compounds.

일반구조식 (1)에서 일반구조식 (2)의 화합물의 합성은 일반구조식 (1)의 화합물을 벤젠, 톨루엔등과 같은 방향족 탄화수소나 또는 기타 반응에 관여하지 않는 통상의 용매중에서 촉매량의 파라톨루엔설폰산, 벤젠설폰산등과 같은 설폰산의 촉매량의 존재하에 에틸렌글리콜과 반응시켜서 제조한다.Synthesis of the compound of the general formula (2) in the general formula (1) is carried out by the catalytic amount of paratoluenesulfonic acid in the aromatic hydrocarbon such as benzene, toluene and the like or in a conventional solvent which is not involved in other reactions. It is prepared by reacting with ethylene glycol in the presence of a catalytic amount of sulfonic acid such as benzene sulfonic acid and the like.

일반구조식 (3)의 화합물의 합성은 일반구조식 (2)의 화합물을 염화메틸렌 등과 같은 염소화탄화수소 용매나 또는 기타 통상의 불활성 용매중에서 셀레늄 디옥사이드등과 같은 산화물의 촉매량 존재하에 t-부틸 하이드로퍼옥사이드와 같은 유기과산화물로 산화시켜서 제조한다.Synthesis of the compound of the general formula (3) is carried out in combination with t-butyl hydroperoxide in the presence of a catalytic amount of an oxide such as selenium dioxide in a chlorinated hydrocarbon solvent such as methylene chloride or other common inert solvents. Prepared by oxidation with the same organic peroxide.

일반구조식 (4)의 화합물의 합성은 통상의 반응조건하에서 일반구조식 (3)의 화합물을 DMF, 염화메틸렌 및 기타 통상의 불활성 유기용매중에서 통상의 할로겐화제로 할로겐화시켜서 제조한다.Synthesis of the compound of general formula (4) is prepared by halogenating the compound of general formula (3) with conventional halogenating agents in DMF, methylene chloride and other common inert organic solvents under conventional reaction conditions.

일반구조식 (5)의 화합물로부터 일반구조식 (6)의 화합물의 제조는 벤젠, 톨루엔, 헥산 등과 같은 지방족 탄화수소 또는 방향족탄화수소나 또는 기타 반응에 관여하지않는 통상의 불활성 용매중에서 PBr3, PCl3, 및 통상의 할로겐화제로 할로겐화시켜서 제조한다.Preparation of compound represented by the general formula (6) from a compound represented by the general formula (5) PBr 3, PCl 3, and from conventional inert solvents which do not take part in an aliphatic hydrocarbon or aromatic hydrocarbon or or other reaction such as benzene, toluene, hexane Prepared by halogenation with a conventional halogenating agent.

일반구조식 (7)화합물의 제조는 일반구조식 (6)의 화합물을 DMF, 테트라하이드로퓨란 및 기타 통상의 불활성 유기용매중에서 메탄설핀산, 벤젠설핀산 또는 톨루엔설핀산등과 같은 설핀산의 알칼리금속염과 반응시켜서 제조한다.Preparation of the compound of the general formula (7) may be carried out by combining the compound of the general formula (6) with an alkali metal salt of sulfinic acid, such as It is made by reaction.

이를 반응식으로 표시하면 다음과 같다.This is expressed as a reaction scheme as follows.

식중 R, X 및 n은 전술한 바와 같다.Wherein R, X and n are as described above.

본 발명의 방법에 의하면 반응부생물이 발생하지않으며 따라서 순수하게 목적화합물을 제조할 수 있고, 높은 수율로 목적화합물을 제조할 수 있다.According to the method of the present invention, no reaction by-products are generated, and thus the target compound can be prepared purely, and the target compound can be prepared in high yield.

본 발명에서 제조되는 중간화합물들은 모두 신규의 물질들이며 이들 신규의 물질 및 그 제조방법도 또한 본 발명의 범위내에 포함된다.The intermediate compounds produced in the present invention are all novel materials and these novel materials and preparation methods thereof are also included within the scope of the present invention.

다음에 실시에로서 본 발명을 더욱 상세히 설명한다.Next, the present invention will be described in more detail with reference to Examples.

[실시예 1]Example 1

6, 10-디메틸-5,9-운데칸디엔-2-온 에틸렌 아세탈의 합성Synthesis of 6, 10-dimethyl-5,9-undecanedien-2-one ethylene acetal

실험방법 : 25ml의 이구 플라스크 제라닐아세톤(97㎎, 5mmol)을 무수 벤젠(10ml)에 녹이고 에틸렌글리콜(435㎎, 7mmol)과 p-TsOH(3㎎)을 가한 후 Dean-Stark 트랩을 장치하고 그위에 환류 냉각기를 장치한 다음 9시간동안 환류했다. 반응 혼합물을 실온으로 식한 후 포화 중탄산나트륨 수용액을 가하여 벤젠층을 분리하고 수층은 석유에테르로 3번 추출하였다.Experimental method: Dissolve 25 ml two-necked flask geranyl acetone (97 mg, 5 mmol) in anhydrous benzene (10 ml), add ethylene glycol (435 mg, 7 mmol) and p-TsOH (3 mg), and then install a Dean-Stark trap. A reflux condenser was installed thereon and refluxed for 9 hours. The reaction mixture was cooled to room temperature, saturated aqueous sodium bicarbonate solution was added to separate the benzene layer, and the aqueous layer was extracted three times with petroleum ether.

모아진 유기층을 물로 씻고 무수 황산마그네슘으로 건조, 여과한 후 감압농축하여 조생성물을 얻었다. 이 조생성물은 벤젠으로 관 크로마토그래피를 이용하여 오일(1.11G, 93%)을 얻었다.The combined organic layers were washed with water, dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to obtain a crude product. This crude product was obtained by column chromatography on benzene to give an oil (1.11G, 93%).

1H NMR(CDCl3) : δ5.09(m, 2H) 3.9(s, 4H) 1.8-2.16(m, 8H) 1.66(s, 3H) 1.56(s, 6H) 1.30(s, 3H) 1 H NMR (CDCl 3 ): δ 5.09 (m, 2H) 3.9 (s, 4H) 1.8-2.16 (m, 8H) 1.66 (s, 3H) 1.56 (s, 6H) 1.30 (s, 3H)

IR(Vmax, cm-1) : 2970, 2870, 1440, 1380, 1220, 1135, 1055, 950, 865IR (Vmax, cm -1 ): 2970, 2870, 1440, 1380, 1220, 1135, 1055, 950, 865

[실시예 2]Example 2

11-히드록시-6,10-디메틸-5,9-운데칸디엔-2-온 에틸렌 아세탈의 합성Synthesis of 11-hydroxy-6,10-dimethyl-5,9-undecanedien-2-one ethylene acetal

실험방법 : 25ml의 플라스크에 셀레니움 디옥사이드(55, 48㎎, 0.5mmol)을 디클로메탄에 현탁시킨 후 70% t-부틸 하이드로퍼옥사이드(180.24㎎, 0.5mmol)을 넣고 빛을 차단한 상태에서 30분 동안 교반하면서, 0℃하에서 6,10-디메틸-5,9-운데칸디엔-2-온 에틸렌 아세탈(238㎎, 1.0mmol)을 적가했다. 반응 혼합물을 10℃로 유지하며 5시간 동안 교반하고 디클로로메탄으로 희석시킨다. 엷은 노란색의 희석액을 물과 묽은 수산화나트륨 수용액으로 씻어주고 다시 물과 소금물로 씻어준 다음 무수 황산나트륨으로 건조, 여과하고, 감압농축하여 노락색의 오일을 얻었다. 노란색의 오일을 5ml의 메탄올에 녹이고 얼음 중탕을 사용하여 냉각시킨 다음 소디움 보로하이드라이드(22㎎)을 가하고 실온에서 40분동안 교반했다. 용매를 감압하에서 증발시키고 여액에 같은 양의 에테르와 물을 가한 다음 에테르로 3번 추출하였다. 모아진 유기층을 물과 소금물로 씻어주고 무수 황산마그네슘으로 건조, 여과한 후 감압 농축하여 조생성물을 얻었다. 이 조 생성물을 에틸 아세테이트와 헥산(1 : 3) 혼합용액으로 관 크로마토그래피를 이용하여 무색의 오일(104㎎, 41%)을 얻었다.Experimental Method: Suspension of selenium dioxide (55, 48 mg, 0.5 mmol) in dichloromethane in a 25 ml flask was added with 70% t-butyl hydroperoxide (180.24 mg, 0.5 mmol) and blocked in light 30 While stirring for 6 minutes, 6,10-dimethyl-5,9-undecanedien-2-one ethylene acetal (238 mg, 1.0 mmol) was added dropwise at 0 ° C. The reaction mixture is kept at 10 ° C., stirred for 5 hours and diluted with dichloromethane. The pale yellow diluent was washed with water and dilute aqueous sodium hydroxide solution, washed with water and brine again, dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to give a yellow oil. The yellow oil was dissolved in 5 ml of methanol, cooled using an ice bath, sodium borohydride (22 mg) was added and stirred at room temperature for 40 minutes. The solvent was evaporated under reduced pressure, the same amount of ether and water was added to the filtrate and then extracted three times with ether. The combined organic layers were washed with water and brine, dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to obtain a crude product. The crude product was purified by column chromatography with ethyl acetate and hexane (1: 3) mixed solution to give a colorless oil (104 mg, 41%).

1H NMR(CDCl3) : δ4.96-5.56(m, 2H) 3.98(s, 2H) 3.96(s, 4H) 1.96-2.16(m, 8H) 1.67(s, 6H) 1.33(s, 3H) 1 H NMR (CDCl 3 ): δ 4.96-5.56 (m, 2H) 3.98 (s, 2H) 3.96 (s, 4H) 1.96-2.16 (m, 8H) 1.67 (s, 6H) 1.33 (s, 3H)

IR(Vmax, cm-1) : 3400, 2870, 1380, 1270, 1060, 950, 860IR (Vmax, cm -1 ): 3400, 2870, 1380, 1270, 1060, 950, 860

[실시예 3]Example 3

11-클로로-6,10-디메틸-5,9-운데칸디엔-2-온 에틸렌 아세탈의 합성Synthesis of 11-chloro-6,10-dimethyl-5,9-undecanedien-2-one ethylene acetal

실험방법 : 10ml의 플라스크에 알릴 알코올(254㎎, 1mmol)과 2,4,6-콜리딘(133㎎, 1.1mmol)을 넣고 질소기류를 통하면서 교반한 다음 약간양의 무수 DMF에 녹인 리튬클로라이드(42㎎, 1mmol)을 가하고 0℃로 냉각하였다. 여기에 메탄설포닐클로라이드(85μl, 1.1mmol)을 적가하고 같은 온도에서 1시간 30분 동안 교반했다. 반응혼합물에 냉각된 물을 가하고 수층은 펜탄으로 3번 추출하였다. 모아진 유기층을 물과 포화된 질산구리 수용액으로 여러번 씻은 다음 계속해서 물과 소금물로 씻고 무수 황산나트륨으로 건조, 여과한 후 감압농축하여 오일(257㎎, 94%)을 얻었다.Experimental Method: Put allyl alcohol (254 mg, 1 mmol) and 2,4,6-collidine (133 mg, 1.1 mmol) in a 10 ml flask, stir through a stream of nitrogen, and dissolve in a small amount of anhydrous DMF. (42 mg, 1 mmol) was added and cooled to 0 ° C. Methanesulfonyl chloride (85 µl, 1.1 mmol) was added dropwise thereto and stirred at the same temperature for 1 hour 30 minutes. Cooled water was added to the reaction mixture, and the aqueous layer was extracted three times with pentane. The combined organic layers were washed several times with water and saturated aqueous copper nitrate solution, and subsequently washed with water and brine, dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give an oil (257 mg, 94%).

1H NMR(CDCl3) : δ5.50(m, 1H) 5.13(m, 1H) 4.03(s, 2H) 3.96(s, 4H) 1.90-2.26(m, 8H) 1.73(s, 3H) 1.63(s, 3H) 1.33(s, 3H) 1 H NMR (CDCl 3 ): δ5.50 (m, 1H) 5.13 (m, 1H) 4.03 (s, 2H) 3.96 (s, 4H) 1.90-2.26 (m, 8H) 1.73 (s, 3H) 1.63 ( s, 3H) 1.33 (s, 3H)

IR(Vmax, cm-1) : 2970, 2930, 2870, 1440, 1380, 1260, 1210, 1135, 1055, 940, 870, 685IR (Vmax, cm -1 ): 2970, 2930, 2870, 1440, 1380, 1260, 1210, 1135, 1055, 940, 870, 685

[실시예 4]Example 4

제라닐 브로마이드의 합성Synthesis of Geranyl Bromide

실험방법 : 10ml의 이구플라스크에 제라니올(400㎎, 2.59mmol)을 3ml의 무수헥산에 녹이고 얼음 중탕을 사용하여 냉각하였다. 여기에 질소가스를 통하고 교반하면서 포스포러스 트리브로마이드(351㎎, 1.30mmol)을 가한 후 같은 온도에서 30분간 더 교반했다. 반응혼합물에 메탄올을 가한 후 찬 포화 중탄산나트륨 수용액과 찬 소금물로 씻고 무수 황산마그네슘으로 건조했다. 용매를 감압하에서 증발시켜 무색의 오일(609㎎, 95%)을 얻었다. 이 물질은 대단히 불안정하여 정제하지 않고 곧 다음 반응에 사용했다.Experimental Method: Geraniol (400 mg, 2.59 mmol) was dissolved in 3 ml of anhydrous hexane in a 10 ml two-necked flask and cooled using an ice bath. Phosphorus tribromide (351 mg, 1.30 mmol) was added thereto while stirring through nitrogen gas, followed by further stirring at the same temperature for 30 minutes. Methanol was added to the reaction mixture, which was then washed with cold saturated aqueous sodium bicarbonate solution and cold brine and dried over anhydrous magnesium sulfate. The solvent was evaporated under reduced pressure to give a colorless oil (609 mg, 95%). This material was so unstable that it was used for the next reaction without purification.

1H NMR(CDCl3) : δ5.42(t, J=9Hz, 1H), 5.10(broad signal, 1H) 3.97(d, J=2hZ, 2H) 2.05(s, 4H) 1.69(s, 6H) 1.60(s, 3H) 1 H NMR (CDCl 3 ): δ5.42 (t, J = 9Hz, 1H), 5.10 (broad signal, 1H) 3.97 (d, J = 2hZ, 2H) 2.05 (s, 4H) 1.69 (s, 6H) 1.60 (s, 3 H)

IR(Vmax, cm-1) : 2950-3000, 1675, 1380IR (Vmax, cm -1 ): 2950-3000, 1675, 1380

[실시예 5]Example 5

제라닐 페닐 설폰의 합성Synthesis of Geranyl Phenyl Sulfone

실험방법 : 10ml의 이구플라스크에 제라닐브로마이드(500㎎, 2.303mmol)을 5ml 무수 DMF에 녹이고 벤젠설폰산(나트륨염, 98%)(690㎎, 4.202mmol)을 가한다음 질소가스를 통하면서 20시간 동안 교반했다. 반응혼합물을 물로 묽히고, 에테르로 2번 추출하였다. 모아진 유기층을 소금물로 씻고 무수 황산 마그네슘으로 건조, 여과한 후 감압농축하여 조생성물을 얻었다. 이 조생성물을 에틸아세테이트와 헥산(1 : 10) 혼합용액으로 관 크로마토그래피를 이용하여 엷은 노란색의 오일(460㎎, 72%)을 얻었다.Experimental Method: Dissolve geranyl bromide (500 mg, 2.303 mmol) in 5 ml anhydrous DMF in a 10 ml two-neck flask, add benzenesulfonic acid (sodium salt, 98%) (690 mg, 4.202 mmol), and add 20 mL of nitrogen. Stirred for hours. The reaction mixture was diluted with water and extracted twice with ether. The combined organic layers were washed with brine, dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to obtain a crude product. The crude product was purified by column chromatography using ethyl acetate and hexane (1: 10) mixed solution to obtain a pale yellow oil (460 mg, 72%).

1H NMR(CDCl3) : δ7.85(m, 2H) 7.50(m, 3H) 4.8-5.33(s, 2H) 3.75(d, J=8Hz, 2H) 1.98(m, 4H) 1.66(s, 3H) 1.56(s, 3H) 1.33(s, 3H) 1 H NMR (CDCl 3 ): δ 7.85 (m, 2H) 7.50 (m, 3H) 4.8-5.33 (s, 2H) 3.75 (d, J = 8 Hz, 2H) 1.98 (m, 4H) 1.66 (s, 3H) 1.56 (s, 3H) 1.33 (s, 3H)

IR(Vmax, cm-1) : 2970, 2870, 1440, 1380, 1310, 1140IR (Vmax, cm -1 ): 2970, 2870, 1440, 1380, 1310, 1140

[실시예 6]Example 6

6,10,14,18-테트라메틸-10(페닐설포닐)-5,9,13,17-노나데카테트라엔-2-온 에틸렌 아세탈의 합성Synthesis of 6,10,14,18-tetramethyl-10 (phenylsulfonyl) -5,9,13,17-nonadecatetraen-2-one ethylene acetal

실험방법 : 25ml의 이구 플라스크에 소디움 하이드라이드(60%)(48㎎, 1mmol)을 7ml의 무수 DMF에 현탁시킨 다음 얼음용으로 냉각하고 질소기류를 통하면서 1ml의 무수 DMF에 녹인 제라닐 페닐 설폰(278㎎, 1mmol)을 가한다. 얼음욕을 제거하고 30분동안 교반했다. 이 반응 혼합물에 11-클로로-6,10디메닐-5,9-운데카디엔-2-온 에틸렌 아세탈(273㎎, 1mmol)을 가하고 상온에서 5시간 동안 교반한 다음 냉각된 5% 염산으로 반응을 중지시키고 에테르로 3번 추출하였다. 모아진 유기층 소금물로 2번 씻고 무수 황산 마그네슘으로 건조, 여과한 후 감압농축하여 조생성물을 얻었다. 이 조생성물을 에틸아세테이트-헥산(1 : 4) 혼합용액으로 관 크로마토그래피를 이용하여 오일(313㎎, 61%)을 얻었다.Test Method: Sodium hydride (60%) (48 mg, 1 mmol) was suspended in 7 ml of anhydrous DMF in a 25 ml two-necked flask, then cooled for ice and dissolved in 1 ml of anhydrous DMF while passing through a nitrogen stream. (278 mg, 1 mmol) is added. The ice bath was removed and stirred for 30 minutes. 11-Chloro-6,10dimenyl-5,9-undecadien-2-one ethylene acetal (273 mg, 1 mmol) was added to the reaction mixture, which was stirred at room temperature for 5 hours, followed by reaction with cooled 5% hydrochloric acid. Stopped and extracted three times with ether. The combined organic layer was washed twice with brine, dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to obtain a crude product. This crude product was purified by column chromatography with ethyl acetate-hexane (1: 4) mixed solution to obtain an oil (313 mg, 61%).

1H NMR(CDCl3) : δ7.86(m, 2H) 7.54(m, 3H) 4.90-5.33(m, 4H) 3.96(s, 4H) 3.70-4.13(m, 1H) 1.90-2.23(m, 14H) 1.70(s, 6H) 1.61(s, 6H) 1.36(s, 3H) 1.26(s, 3H) 1 H NMR (CDCl 3 ): δ 7.86 (m, 2H) 7.54 (m, 3H) 4.90-5.33 (m, 4H) 3.96 (s, 4H) 3.70-4.13 (m, 1H) 1.90-2.23 (m, 14H) 1.70 (s, 6H) 1.61 (s, 6H) 1.36 (s, 3H) 1.26 (s, 3H)

IR(Vmax, cm-1) : 2970, 2870, 1440, 1380, 1310, 1220, 1135IR (Vmax, cm -1 ): 2970, 2870, 1440, 1380, 1310, 1220, 1135

[실시예 7]Example 7

6,10,14,18-테트라메틸-5,9,13,17-노나데카테트라엔-2-온 에틸렌 아세탈의 합성Synthesis of 6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraen-2-one ethylene acetal

실험방법 : 100ml의 이구 플라스크의 설폰 화합물(514㎎, 1mmol)과 디소디움 하이드로젠 포스페이트(568㎎, 4mmol)을 50ml의 무수 메탄올에 녹인 다음, 질소기류를 통하면서 -10℃에서 6% 소디움 아말감(1.5g, 4mmol)을 한번에 가하였다. 이 혼합물을 -10℃에서 20분 동안 교반한 다음 포화된 염화암모늄 수용액으로 반응을 중지시키고 에테르로 추출하였다. 모아진 유기층을 포화 중탄산나트륨 수용액으로 씻고 무수항산 마그네슘으로 건조, 여과한 후 감압농축하여 조생성물을 얻었다. 이 조생성물을 6% 에틸아세테이트-헥산 혼합용액으로 관 크로마토그래피를 이용하여 오일(307㎎, 82%)을 얻었다.Experimental Method: Dissolve 100 ml of two-necked flask of sulfone compound (514 mg, 1 mmol) and disodium hydrogen phosphate (568 mg, 4 mmol) in 50 ml of anhydrous methanol, and 6% sodium amalgam at -10 ° C through nitrogen stream. (1.5 g, 4 mmol) was added in one portion. The mixture was stirred at −10 ° C. for 20 minutes and then quenched with saturated aqueous ammonium chloride solution and extracted with ether. The combined organic layers were washed with saturated aqueous sodium bicarbonate solution, dried over anhydrous magnesium hydroxide, filtered and concentrated under reduced pressure to obtain a crude product. The crude product was purified by column chromatography with 6% ethyl acetate-hexane mixed solution to give an oil (307 mg, 82%).

1H NMR(CDCl3) : δ5.02-5.18(m, 4H) 4.00(s, 4H) 1.98-2.26(m, 16H) 1.68(s, 3H) 1.58(2, 12H),1.33(s, 3H) 1 H NMR (CDCl 3 ): δ 5.02-5.18 (m, 4H) 4.00 (s, 4H) 1.98-2.26 (m, 16H) 1.68 (s, 3H) 1.58 (2, 12H), 1.33 (s, 3H )

IR(Vmax, cm-1) : 2970, 2870, 1440, 1380, 1210, 1135, 950, 865IR (Vmax, cm -1 ): 2970, 2870, 1440, 1380, 1210, 1135, 950, 865

[실시예 8]Example 8

6,10,14,18-테트라메틸-5,9,13,17-노나데카테트라엔-2-온의 합성Synthesis of 6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraen-2-one

실험방법 : 25ml 플라스크에 6,10,14,18-테트라메틸-5,9,13,17-노나데카테트라엔-2-온 에틸렌 아세탈(420㎎, 1.033mmol)을 가한 다음 3시간 동안 환류했다. 반응 혼합물을 물로 묽힌 후 디클로로메탄으로 3번 추출하였다. 모아진 유기층을 물과 소금물로 씻어주고 무수 황산마그네슘으로 건조, 여과한 후 감압농축하여 조생성물을 얻었다. 이 조생성물을 에틸아세테이트와 벤젠(2 :98) 혼합용액으로 관 크로마토그래피를 이용하여 무색의 오일(323㎎, 98%)을 얻었다.Experimental Method: 6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraen-2-one ethylene acetal (420 mg, 1.033 mmol) was added to a 25 ml flask and refluxed for 3 hours. . The reaction mixture was diluted with water and extracted three times with dichloromethane. The combined organic layers were washed with water and brine, dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to obtain a crude product. The crude product was purified by column chromatography with ethyl acetate and benzene (2:98) mixed solution to give a colorless oil (323 mg, 98%).

1H NMR(CDCl3) : δ5.02-5.18(m, 4H) 2.26-2.54(m, 4H) 1.98-2.13(m, 15H) 1.68-s, 3H) 1.60(s, 12H) 1 H NMR (CDCl 3 ): δ 5.02-5.18 (m, 4H) 2.26-2.54 (m, 4H) 1.98-2.13 (m, 15H) 1.68-s, 3H) 1.60 (s, 12H)

IR(Vmax, cm-1) : 1690, 1660, 1380IR (Vmax, cm -1 ): 1690, 1660, 1380

[실시예 9]Example 9

6-메틸-5(E)-헵텐-2-온 에틸렌 아세탈의 합성Synthesis of 6-methyl-5 (E) -hepten-2-one ethylene acetal

실험방법 : 50ml의 이구 플라스크에 6-메틸-5(E)-헵텐-2-온(1.26㎎, 10mmol)을 무수 벤젠(25ml)에 녹이고 에틸렌글리콜(0.87g, 14mmol)과 p-톨루엔설폰산(5㎎)을 가한 후 Dean-Stark 트랩을 장치하고 그 위에 환류냉각기를 장치한 다음 9시간 동안 환류했다. 반응혼합물을 실온으로 식힌 후 포화중탄산나트륨 수용액을 가하여 벤젠층을 분리하고 수층은 석유에테르로 3번 추출하였다. 모아진 유기층을 물로 씻고 무수황산 마그네슘으로 건조, 여과한 후 감압농축하여 조생성물을 얻었다. 이 조생성물은 벤젠으로 관 크로마토그래피를 이용하여 오일(1.55g, 91%)을 얻었다.Experimental Method: Dissolve 6-methyl-5 (E) -hepten-2-one (1.26 mg, 10 mmol) in 50 ml two-necked flask in anhydrous benzene (25 ml), and use ethylene glycol (0.87 g, 14 mmol) and p-toluenesulfonic acid. (5 mg) was added followed by a Dean-Stark trap, reflux cooler on it, and refluxed for 9 hours. After cooling the reaction mixture to room temperature, saturated aqueous sodium bicarbonate solution was added to separate the benzene layer, and the aqueous layer was extracted three times with petroleum ether. The combined organic layers were washed with water, dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to obtain a crude product. This crude product was obtained by column chromatography on benzene to give an oil (1.55 g, 91%).

1H NMR(CDCl3) : δ4.90-5.30(m, 1H) 3.92(s, 4H) 2.20-2.50(m, 4H) 1.70(s, 3H) 1.63(s, 3H) 1.30(s, 3H) 1 H NMR (CDCl 3 ): δ 4.90-5.30 (m, 1H) 3.92 (s, 4H) 2.20-2.50 (m, 4H) 1.70 (s, 3H) 1.63 (s, 3H) 1.30 (s, 3H)

IR(Vmax, cm-1) : 2970, 1460, 1380, 1220, 1050IR (Vmax, cm -1 ): 2970, 1460, 1380, 1220, 1050

[실시예 10]Example 10

7-히드록시-6-메틸-5(E)-헵텐-2-온 에틸렌 아세탈의 합성Synthesis of 7-hydroxy-6-methyl-5 (E) -hepten-2-one ethylene acetal

실험방법 : 200ml의 이구 플라스크에 셀레니움 디옥사이드(0.55g, 5mmol)을 디클로로메탄에 현탁시킨 후 70% t-부틸 히드로퍼옥사이드(1.8g, 5mmol)을 넣고 빛을 차단한 상태에서 30분 동안 교반하면서 0℃ 하에서 6-메틸-5(E)-헵텐-2-온 에틸렌 아세탈(1.7g, 10mmol)을 적가했다. 반응혼합물을 10℃로 유지하며 5시간 동안 교반하고 디클로로메탄으로 희석시킨다. 엷은 노란색의 희석액을 물과 묽은 수산화나트륨 수용액으로 씻어주고 다시 물과 소금물로 씻어준 다음 무수 황산 나트륨으로 건조, 여과하고 감압농축하여 노란색의 오일을 얻었다. 노란색의 오일을 25ml의 메탄올에 녹이고 얼음중탕을 사용하여 냉각시킨 다음 소디움보로하이드라이드(220㎎)을 가하고 실온에서 30분 동안 교반했다. 용매를 감압하에서 증발시키고 여액에 같은 양의 에테르와 물을 가한 다음 에테르로 3번 추출하였다. 모아진 유기층을 물과 소금물로 씻어주고 무수 황산마그네슘으로 건조, 여과한 후 감압농축하여 조생성물을 얻었다. 이 조생성물을 에틸아세테이트와 헥산(1 : 4) 혼합용액으로 관 크로마토그래피를 이용하여 무색의 오일(1.36g, 73%)을 얻었다.Experimental method: Suspension of selenium dioxide (0.55g, 5mmol) in dichloromethane in a 200ml two-necked flask and add 70% t-butyl hydroperoxide (1.8g, 5mmol) while stirring for 30 minutes while blocking the light. 6-methyl-5 (E) -hepten-2-one ethylene acetal (1.7 g, 10 mmol) was added dropwise at 0 ° C. The reaction mixture is kept at 10 ° C., stirred for 5 hours and diluted with dichloromethane. The pale yellow diluent was washed with water and dilute aqueous sodium hydroxide solution, washed with water and brine again, dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give a yellow oil. The yellow oil was dissolved in 25 ml of methanol, cooled using an ice bath, sodium borohydride (220 mg) was added and stirred at room temperature for 30 minutes. The solvent was evaporated under reduced pressure, the same amount of ether and water was added to the filtrate and then extracted three times with ether. The combined organic layers were washed with water and brine, dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to obtain a crude product. The crude product was purified by column chromatography using ethyl acetate and hexane (1: 4) mixed solution to obtain a colorless oil (1.36 g, 73%).

1H NMR(CDCl3) : δ5.40(t, J-7Hz, 1H), 3.97(s, 2H), 3.92(s, 4H) 2.10(m, 2H) 1.60(m, 2H) 1.65(s, 3H) 1.30(s, 3H) 1 H NMR (CDCl 3 ): δ5.40 (t, J-7Hz, 1H), 3.97 (s, 2H), 3.92 (s, 4H) 2.10 (m, 2H) 1.60 (m, 2H) 1.65 (s, 3H) 1.30 (s, 3H)

IR(Vmax, cm-1) : 3400(broad peak), 2970, 2920, 2870, 1445, 1380, 1220, 1135, 1055, 950, 865IR (Vmax, cm -1 ): 3400 (broad peak), 2970, 2920, 2870, 1445, 1380, 1220, 1135, 1055, 950, 865

[실시예 11]Example 11

7-클로로-6-메틸-5(E)-헵텐-2-온 에틸렌 아세탈의 합성Synthesis of 7-chloro-6-methyl-5 (E) -hepten-2-one ethylene acetal

실험방법 : 10ml의 플라스크에 알릴 알코올(988㎎, 5.31mmol)과 2,4,6-콜리딘(926μl, 7.01mmol)을 넣고 질소기류를 통하면서 교반한 다음 약간양의 무수 DMF에 녹인 리튬 클로라이드(550㎎, 13mmol)을 가하고 0℃로 냉각하였다. 여기에 메탄 설포닐 클로라이드(566μl), 7.31mmol)을 방울씩 가하고 같은 온도에서 1시간 30분동안 교반했다. 반응혼합물에 냉각된 물을 가하고 수층은 펜탄으로 3번 추출하였다. 모아진 유기층을 물과 포화된 질산구리 수용액으로 여러번 씻은 다음 계속해서 물과 소금물로 씻고 무수 황산 나트륨으로 건조, 여과한 후 감압농축하여 오일(1.012g, 93%)을 얻었다.Experimental Method: Put allyl alcohol (988 mg, 5.31 mmol) and 2,4,6-collidine (926 μl, 7.01 mmol) in a 10 ml flask, stir through a stream of nitrogen, and dissolve in a small amount of anhydrous DMF. (550 mg, 13 mmol) was added and cooled to 0 ° C. Methane sulfonyl chloride (566 µl) and 7.31 mmol) were added dropwise thereto, followed by stirring at the same temperature for 1 hour 30 minutes. Cooled water was added to the reaction mixture, and the aqueous layer was extracted three times with pentane. The combined organic layers were washed several times with water and saturated aqueous copper nitrate solution, and subsequently washed with water and brine, dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to obtain an oil (1.012 g, 93%).

1H NMR(CDCl3) : δ5.53(t, J=7.6Hz, 1H) 4.00(s, 2H) 3.91(s, 4H) 2.11(m, 2H) 1.73(s, 3H) 1.70(m, 2H) 1.31(s, 3H) 1 H NMR (CDCl 3 ): δ5.53 (t, J = 7.6Hz, 1H) 4.00 (s, 2H) 3.91 (s, 4H) 2.11 (m, 2H) 1.73 (s, 3H) 1.70 (m, 2H ) 1.31 (s, 3H)

IR(Vmax, cm-1) : 2970, 2930, 2870, 1440, 1380, 1260, 1210, 1135, 1055, 940, 865, 685IR (Vmax, cm -1 ): 2970, 2930, 2870, 1440, 1380, 1260, 1210, 1135, 1055, 940, 865, 685

[실시예 12]Example 12

파르네실 브로마이드의 합성Synthesis of Farnesyl Bromide

실험방법 : 25ml의 이구 플라스크에 파르네숄(889㎎, 4mmol)을 4ml의 무수 헥산에 녹이고 얼음중탕을 사용하여 냉각하였다. 여기에 질소가스를 통하여 교반하면서 포스포러스 트리브로마이드(541㎎, 2mmol)을 가한 후 같은 온도에서 30분간 더 교반했다. 반응혼합물에 메탄올을 가한 후 찬 포화중탄산나트륨 수용액과 찬 소금물로 씻고 무수 황산 마그네슘으로 건조했다. 용매는 감압하에서 증발시켜 무색의 오일(1128㎎, 98.9%)을 얻었다. 이 물질은 대단히 불안정하여 정제하지 않고 곧 다음 반응에 사용했다.Experimental method: In a 25 ml two-necked flask, farnesol (889 mg, 4 mmol) was dissolved in 4 ml of anhydrous hexane and cooled using an ice bath. Phosphorus tribromide (541 mg, 2 mmol) was added thereto while stirring through nitrogen gas, followed by further stirring at the same temperature for 30 minutes. Methanol was added to the reaction mixture, which was then washed with cold saturated aqueous sodium bicarbonate solution and cold brine and dried over anhydrous magnesium sulfate. The solvent was evaporated under reduced pressure to give a colorless oil (1128 mg, 98.9%). This material was so unstable that it was used for the next reaction without purification.

1H NMR(CDCl3) : δ5.10-5.46(m, 3H) 3.97(d, J=7Hz, 2H) 2.1(brs, 8H) 1.6 and 1.7(s, 12H) 1 H NMR (CDCl 3 ): δ 5.10-5.46 (m, 3H) 3.97 (d, J = 7Hz, 2H) 2.1 (brs, 8H) 1.6 and 1.7 (s, 12H)

IR(Vmax, cm-1) : 1665, 1455, 1380, 1180IR (Vmax, cm -1 ): 1665, 1455, 1380, 1180

[실시예 13]Example 13

파르네실 페닐 설폰의 합성Synthesis of Farnesyl Phenyl Sulfone

실험방법 : 25ml의 이구 플라스크에 파트네실 브로마이드(1.14g, 4mmol)을 11ml의 무수 DMF에 녹이고 벤젠설폰산(나트륨염, 98%)(1.2g, 7.3mmol)을 가한 다음 질소가스를 통하면서 20시간 동안 교반했다. 반응혼합물을 물로 묽히고 에테르로 2번 추출하였다. 모아진 유기층을 소금물로 씻고 무수 황산 마그네슘으로 건조, 여과한 후 감압농축하여 조생성물을 얻었다. 이 조생성물을 에틸아세테이트와 헥산(1 : 10) 혼합용액으로 관 크로마토그래피를 이용하여 엷은 노란색의 오일(1.12g, 61%)을 얻었다Experimental Method: Dissolve the particyl bromide (1.14g, 4mmol) in 11ml anhydrous DMF in 25ml two-necked flask, add benzenesulfonic acid (sodium salt, 98%) (1.2g, 7.3mmol) Stirred for hours. The reaction mixture was diluted with water and extracted twice with ether. The combined organic layers were washed with brine, dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to obtain a crude product. The crude product was purified by column chromatography using ethyl acetate and hexane (1: 10) solution to give a pale yellow oil (1.12 g, 61%).

1H NMR(CDCl3) : δ1.33(3H, s) 1.60(3H, s) 1.69(6H, s) 2.0(8H, broa) 3.80(2H, j, J=7Hz) 5.10(2H, m) 5.20(H, t, J=7Hz) 7.50(3H, m) 7.85(2H, m) 1 H NMR (CDCl 3 ): δ1.33 (3H, s) 1.60 (3H, s) 1.69 (6H, s) 2.0 (8H, broa) 3.80 (2H, j, J = 7Hz) 5.10 (2H, m) 5.20 (H, t, J = 7 Hz) 7.50 (3H, m) 7.85 (2H, m)

IR(Vmax, cm-1) : 1450, 1305, 1160, 980IR (Vmax, cm -1 ): 1450, 1305, 1160, 980

[실시예 14]Example 14

6,10,14,18-테트라메틸-6-(페닐설포닐)-5,9,13,17-노나데카테트라엔-2-온 에틸렌 아세탈의 합성Synthesis of 6,10,14,18-tetramethyl-6- (phenylsulfonyl) -5,9,13,17-nonadecatetraen-2-one ethylene acetal

실험방법 : 25ml의 이구 플라스크에 소디움 하이드라이드(60%)(48㎎, 1mmol)을 7ml의 무수 DMF에 현탁시킨 다음 얼음욕으로 냉각하고 질소기류를 통하면서 1ml의 무수 DMF에 녹인 파트네실 페닐 설폰(346㎎, 1mmol)을 가한다. 얼음욕을 제거하고 30분동안 교반했다. 이 반응혼합물에 7-클로로-6-메틸-5-헵텐-2-온 에틸렌 아세탈(205㎎, 1mmol)을 가하고 상온에서 5시간 동안 교반한 다음 냉각된 5% 염산으로 반응을 중지시키고 에테르로 3번 추출하였다. 모아진 유기층을 소금물로 2번 씻고 무수 황산마그네슘으로 건조, 여과한 후 감압농축하여 조생성물을 얻었다. 이 조생성물을 에틸아세테이트-헥산(1 : 4) 혼합용액으로 관 크로마토그래피를 이용하여 오일(324㎎, 63%)을 얻었다.Experimental Method: Sodium hydride (60%) (48 mg, 1 mmol) was suspended in 7 ml of anhydrous DMF in a 25 ml two-necked flask, cooled in an ice bath, and dissolved in 1 ml of anhydrous DMF while passing through a nitrogen stream. (346 mg, 1 mmol) is added. The ice bath was removed and stirred for 30 minutes. 7-Chloro-6-methyl-5-hepten-2-one ethylene acetal (205 mg, 1 mmol) was added to the reaction mixture, which was stirred for 5 hours at room temperature. The reaction was quenched with cooled 5% hydrochloric acid, followed by ether 3 Extracted twice. The combined organic layers were washed twice with brine, dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to obtain a crude product. This crude product was purified by column chromatography with ethyl acetate-hexane (1: 4) mixed solution to give an oil (324 mg, 63%).

1H NMR(CDCl3) : δ7.86(m, 2H) 7.55(m, 3H) 4.90-5.33(m, 4H) 3.96(s, 4H) 3.76-4.20(m, 1H) 1.90-2.23(m, 14H) 1.73(s, 6H) 1.60(s, 6H) 1.36(s, 3H) 1.30(s, 3H) 1 H NMR (CDCl 3 ): δ 7.86 (m, 2H) 7.55 (m, 3H) 4.90-5.33 (m, 4H) 3.96 (s, 4H) 3.76-4.20 (m, 1H) 1.90-2.23 (m, 14H) 1.73 (s, 6H) 1.60 (s, 6H) 1.36 (s, 3H) 1.30 (s, 3H)

IR(Vmax, cm-1) : 2970, 2920, 2870, 1440, 1380, 1310, 1220, 1140IR (Vmax, cm -1 ): 2970, 2920, 2870, 1440, 1380, 1310, 1220, 1140

[실시예 15]Example 15

6,10,14,18-테트라메틸-5,9,13,17-노나데카테트라엔-2-온 에틸렌 아세탈의 합성Synthesis of 6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraen-2-one ethylene acetal

실험방법 : 100ml의 이구 플라스크에 설폰 화합물(514㎎, 1mmol)과 디소디움 하이드로젠 포스페이트(568㎎, 4mmol)을 50ml의 무수 메탄올에 녹인 다음, 질소기류를 통하면서 -10℃에서 6% 소디움 아밀감(1.5g, 4mmol)을 한번에 가하였다. 이 혼합물을 -10℃에서 20분 동안 교반한 다음 포화된 염화암모늄 수용액으로 반응을 중지시키고 에테르로 추출하였다. 모아진 유기층을 포화 중탄산나트륨 수용액으로 씻고 무수 황산마그네슘으로 건조, 여과한 후 감압농축하여 조생성물을 얻었다. 이 조생성물 6% 에틸아세테이트-헥산 혼합용액으로 관 크로마토그래프를 이용하여 오일(307㎎, 82%)을 얻었다.Experimental Method: Dissolve the sulfone compound (514 mg, 1 mmol) and disodium hydrogen phosphate (568 mg, 4 mmol) in 50 ml of anhydrous methanol in a 100 ml two-necked flask, and add 6% sodium at -10 ° C through a nitrogen stream. Mandarin (1.5 g, 4 mmol) was added at one time. The mixture was stirred at −10 ° C. for 20 minutes and then quenched with saturated aqueous ammonium chloride solution and extracted with ether. The combined organic layers were washed with saturated aqueous sodium bicarbonate solution, dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to obtain a crude product. The crude product 6% ethyl acetate-hexane mixed solution was obtained using oil column chromatography (307 mg, 82%).

1H NMR(CDCl3) : δ5.02-5.18(m, 4H) 4.00(s, 4H) 1.98-2.26(m, 16H) 1.68(s, 3H) 1.58(s, 12H) 1.33(s, 3H) 1 H NMR (CDCl 3 ): δ 5.02-5.18 (m, 4H) 4.00 (s, 4H) 1.98-2.26 (m, 16H) 1.68 (s, 3H) 1.58 (s, 12H) 1.33 (s, 3H)

IR(Vmax, cm-1) : 2970, 2870, 1440, 1380, 1210, 1135, 950, 865IR (Vmax, cm -1 ): 2970, 2870, 1440, 1380, 1210, 1135, 950, 865

[실시예 16]Example 16

6,10,14,18-테트라메틸-5,9,13,17-노나데카테트라엔-2-온의 합성Synthesis of 6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraen-2-one

실험방법 : 25ml 플라스크에 6,10,14,18-테트라메틸-5,9,13,17-노나데카테틀엔-2-온 에탈렌 아세탈(420㎎, 1.033mmol)을 5ml의 아세톤에 녹이고 50% 인산(0.41ml, 7.241mmol)을 가한 다음 3시간 동안 환류했다. 반응 혼합물을 물로 묽힌 후 디클르로메탄으로 3번 추출하였다. 모아진 유기층을 물과 소금물로 씻어주고 무수 황산 마그네슘으로 건조, 여과한 후 감압 농축하여 조생성물을 얻었다. 이 조생성물을 에틸아세테이트와 벤젠(2 : 98) 혼합용액으로 관 크로마토그래피를 이용하여 무색의 오일(323㎎, 98%)을 얻었다.Experimental Method: Dissolve 6,10,14,18-tetramethyl-5,9,13,17-nonadecateteten-2-one etal acetal (420 mg, 1.033 mmol) in a 25 ml flask in 5 ml of acetone. 50% phosphoric acid (0.41 ml, 7.241 mmol) was added and then refluxed for 3 hours. The reaction mixture was diluted with water and extracted three times with dichloromethane. The combined organic layers were washed with water and brine, dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to obtain a crude product. The crude product was purified by column chromatography with ethyl acetate and benzene (2: 98) mixed solution to give a colorless oil (323 mg, 98%).

1H NMR(CDCl3) : δ5.02-5.18(m, 4H) 2.26-2.54(m, 4H) 1.98-2.13(m, 4H) 1.98-2.13(m, 15H) 1.63(s, 3H) 1.60(s, 12H) 1 H NMR (CDCl 3 ): δ 5.02-5.18 (m, 4H) 2.26-2.54 (m, 4H) 1.98-2.13 (m, 4H) 1.98-2.13 (m, 15H) 1.63 (s, 3H) 1.60 ( s, 12H)

IR(Vmax, cm-1) : 1690, 1660, 1380IR (Vmax, cm -1 ): 1690, 1660, 1380

Claims (5)

다음 일반식 (4)의 화합물을 일반식 (7)의 화합물과 반응시켜서 얻어진 다음 일반식 (8)의 화합물을 처리하여 다음 일반식 (9)의 화합물을 제조하고, 이 일반식 (9)의 화합물로부터 보호기를 제거하여 일반식 (I)의 화합물을 제조하는 방법.The following compound of formula (4) is obtained by reacting the compound of formula (7) with the compound of formula (7) to treat the compound of formula (8) to produce the compound of formula (9). A process for preparing a compound of formula (I) by removing a protecting group from a compound. 식중, R은 저급알킬, 벤젠, 톨루엔이며, m은 0 또는 1이고, n은 1또는 2이며(단 m이 0이면 n은 2이며, m이 1이면 n도 동시에 1이다.) X는 할로겐 원자이다.Wherein R is lower alkyl, benzene, toluene, m is 0 or 1, n is 1 or 2 (where n is 2 if m is 0 and n is 1 at the same time). It is an atom. 다음 일반식 (5)의 화합물을 처리하여 일반식 (6)의 화합물을 제조하고 이 일반식 (6)의 화합물을 설폰화처리하여 다음 일반식 (7)의 화합물을 제조하는 방법.A process for preparing the compound of formula (6) by treating the compound of formula (5) and sulfonating the compound of formula (6) to produce the compound of formula (7). 식중, R, n, X는 전술한 바와 같다.Wherein R, n and X are as described above. 일반식 (7)의 화합물,A compound of formula (7), 식중, R, n은 전술한 바와 같다.In the formula, R and n are as described above. 일반식 (1)의 화합물을 에틸렌글리콜로 처리하여 일반식 (2)의 화합물을 제조하고, 이 일반식 (2)의 화합물을 산화시켜서 일반식 (3)의 화합물을 제조하고 이 일반식 (3)의 화합물을 할로겐화제로 처리하여 일반식 (4)의 화합물을 제조하는 방법.The compound of formula (1) was treated with ethylene glycol to prepare a compound of formula (2), and the compound of formula (2) was oxidized to prepare a compound of formula (3). A process for preparing the compound of formula (4) by treating the compound of) with a halogenating agent. 식중, m 및 X는 전술한 바와 같다.Wherein m and X are as described above. 일반식 (4)와 화합물.General formula (4) and a compound. 식중, m 및 X는 전술한 바와 같다.Wherein m and X are as described above.
KR1019920008284A 1992-05-16 1992-05-16 Preparation of 6,10,14,18-tetrasmethyl-5,9,13,17-nonadecatetraene-2-one KR950011103B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019920008284A KR950011103B1 (en) 1992-05-16 1992-05-16 Preparation of 6,10,14,18-tetrasmethyl-5,9,13,17-nonadecatetraene-2-one

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019920008284A KR950011103B1 (en) 1992-05-16 1992-05-16 Preparation of 6,10,14,18-tetrasmethyl-5,9,13,17-nonadecatetraene-2-one

Publications (2)

Publication Number Publication Date
KR930023321A KR930023321A (en) 1993-12-18
KR950011103B1 true KR950011103B1 (en) 1995-09-28

Family

ID=19333169

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920008284A KR950011103B1 (en) 1992-05-16 1992-05-16 Preparation of 6,10,14,18-tetrasmethyl-5,9,13,17-nonadecatetraene-2-one

Country Status (1)

Country Link
KR (1) KR950011103B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100524257B1 (en) * 2002-02-19 2005-10-28 구상호 Practical Synthetic Method of Teprenone

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100524257B1 (en) * 2002-02-19 2005-10-28 구상호 Practical Synthetic Method of Teprenone

Also Published As

Publication number Publication date
KR930023321A (en) 1993-12-18

Similar Documents

Publication Publication Date Title
JP4969767B2 (en) Synthesis of cannabinoids
KR100880787B1 (en) Process for Preparing 3,3',5,5',6,6'-hexaalkyl-2,2'-biphenols, 3,3',4,4',5,5'-hexaalkyl-2,2'-biphenols and 3,3',4,4',5,5',6,6'-octaalkyl-2,2'-biphenols
US4208334A (en) Process for preparation of α-tocopherol
KR950011103B1 (en) Preparation of 6,10,14,18-tetrasmethyl-5,9,13,17-nonadecatetraene-2-one
Kulp et al. Reduction of. alpha.,. beta.-diarylacrylonitriles by sodium borohydride
EP0168175B1 (en) Preparation of tamoxifen
US3803252A (en) Process for the preparation of carotenoid compounds
KR101005969B1 (en) Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative
US3830862A (en) Reactions involving carbon tetrahalides with sulfones
US3646222A (en) Method for production of substituted hydroquinones
KR0152518B1 (en) Hydroxylamin derivatives
US3624105A (en) Method for synthesizing rhodoxanthin
JPH07145157A (en) Production of optically active epoxide
US4107181A (en) Useful prostaglandin intermediates
KR910003636B1 (en) Process for the preparation of benzophenon oxime compounds
Fukata et al. Cyclodienones. Part 6. Preparation of 4-azido-2, 4, 6-tri-t-butyl-cyclohexa-2, 5-dienone and its thermal, photo-, and acid-catalyzed decomposition
US4058567A (en) Cyclopentene sulfoxides
US4988825A (en) Oxidation of aldehydes and ketones using alkali metal perborates
US4532081A (en) Synthesis of 11-deoxyprostaglandins
March et al. Alkylation of Position C‐5 of Triacetic Acid Lactone by [2, 3] Sigmatropic Rearrangement of Sulphonium Ylides
US4900858A (en) Process for the preparation of a 6-halo-3-methyl-1-trialkylsilyloxy-1,3,5-hexatriene
JP3590980B2 (en) Optically active tertiary phosphine compound, transition metal complex having the same as ligand, and use thereof
US5382682A (en) Nitroanilides and their preparation
JPH058691B2 (en)
KR910001236B1 (en) Process for the preparation of 2-(4-amino phenyl0-2-methyl propyl alcohol

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20000928

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee